publications

ANGION PUBLICATIONS

Financial Impact of Delayed Graft Function in Kidney Transplantation June 2020 — Clinical Transplantation
The Effect of ANG-3777 on Hepatocyte Growth Factor Receptor c-Met Signaling May 2020 – American Transplant Congress
The Evolution of Renal Graft Failure Risk: The Power of the Proximal May 2020 – American Transplant Congress
In vivo phosphorylation of c-MET by ANG-3777, a hepatocyte growth factor mimetic May 2020 – American Transplant Congress
ANG-3777 Treatment Attenuates Ischemia-Reperfusion-Induced Renal Injury in Rat and Dog Models May 2020 – American Transplant Congress
ANG-3777, a Hepatic Growth Factor Mimetic, Attenuates Mercuric Chloride-Induced Renal Dysfunction and Mortality in Rats May 2020 – American Transplant Congress
Potential Cost-Savings Associated with ANG-3777 for the Treatment of Delayed Graft Function May 2020 – American Transplant Congress
The 1-Year Incremental Costs of Delayed Graft Function (DGF) in Commercially Insured Kidney Transplant Patients Under 65 May 2020 – American Transplant Congress
Late intervention with the small molecule BB3 mitigates postischemic kidney injury. August 2016 – American Journal of Physiology – Renal Physiology
Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focalcerebral ischemia in rats and mice June 2015 – Journal of Cerebral Blood Flow & Metabolism
Delayed Graft Function (DGF) in Kidney Transplantation Patients: An Analysis of Disease Burden November 2019 – American Society of Nephrology Annual Meeting
Impact of delayed graft function (DGF) on length of stay after a deceased donor kidney transplant November 2019 – American Society of Nephrology Annual Meeting
A Modified Ellipsoid Formula for Estimating Total Kidney Volume November 2019 – American Society of Nephrology Annual Meeting
Machine Learning and Glomerular Remodeling November 2019 – American Society of Nephrology Annual Meeting
Remodeling of the Glomerular Tuft in Proteinuric Kidney Disease November 2019 – American Society of Nephrology Annual Meeting
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholicliver disease. June 2017 – World Journal of Gastroenterology
An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal RecessivePolycystic Kidney Disease-The Nieto-Narayan Formula. October 2016 – PLOS One
Acute injury in natural diet-induced fatty livers – a model for therapy development August 2015 – Recent Patents on Biomarkers
A Biomarker Cluster for Polycystic Kidney Disease: Correlation with Cystic Index March 2015 – Recent Patents on Biomarkers
Injectable microspheres for extended delivery of bioactive insulin and salicylic acid February 2015 – Journal of Bioactive and Compatible Polymers